Bioheart, Inc.

(NASDAQ:BHRT)

1.20

+0.15 (14.29%)

Dec 02 - Close

Open
1.11
High
1.37
Low
1.11
Vol.
3.39K
Mkt Cap
15.17M
52Wk High
5.25
52Wk Low
0.83
Avg. Vol.
9.10K
P/E (Trailing)
-0.80
Beta
0.26
Short %
0.10%
Div. Yield
—

After-Hours 1.22 +0.02 (1.67%) Tue, 2 Dec 2008 7:40 PM

Company Profile

Bioheart, Inc.

13794 NW 4th Street

Sunrise, FL 33325

United States - Map

Phone: (954) 835-1500

Fax: (954) 845-9976

Website: www.bioheartinc.com

State of incorporation: Florida

CEO: Howard J. Leonhardt

Employees: 28

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Bio-tech co focus on discovery/dvlp of cell therap

A biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage.

Recent news for BHRT

Recent opinions on BHRT

No recent Opinions for BHRT

No members own BHRT

Member sentiment: Neutral